Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells

Although significant advancement has been made in the induced pluripotent stem cell (iPSC) field, current methods for iPSC derivation are labor intensive and costly. These methods involve manual selection, expansion, and characterization of multiple clones for each reprogrammed cell sample and therefore significantly hampers the feasibility of studies where a large number of iPSCs need to be derived. To develop higher throughput iPSC reprogramming methods, we generated iPSCs as a pooled culture using rigorous cell surface pluripotent marker selection with TRA-1-60 or SSEA4 antibodies followed by Magnetic Activated Cell Sorting (MACS). We observed that pool-selected cells are similar or identical to clonally derived iPSC lines from the same donor by all criteria examined, including stable expression of endogenous pluripotency genes, normal karyotype, loss of exogenous reprogramming factors, and in vitro spontaneous and lineage directed differentiation potential. This strategy can be generalized for iPSC generation using both integrating and non-integrating reprogramming methods. Our studies provide an attractive alternative to clonal derivation of iPSCs using rigorously selected cell pools and is amenable to automation.

[1]  Wolfgang Wagner,et al.  To Clone or Not to Clone? Induced Pluripotent Stem Cells Can Be Generated in Bulk Culture , 2013, PloS one.

[2]  S. Duncan,et al.  Differentiation of hepatocytes from pluripotent stem cells. , 2013, Current protocols in stem cell biology.

[3]  Yi Zhang,et al.  Genetic and epigenetic variations in iPSCs: potential causes and implications for application. , 2013, Cell stem cell.

[4]  P. Burridge,et al.  Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism. , 2015, European heart journal.

[5]  P. Gadue,et al.  Generation of human induced pluripotent stem cells from peripheral blood using the STEMCCA lentiviral vector. , 2012, Journal of visualized experiments : JoVE.

[6]  Brian S. Clark,et al.  JD induced pluripotent stem cell–derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia , 2012, Hepatology.

[7]  S. Duncan,et al.  Aneuploidy is permissive for hepatocyte-like cell differentiation from human induced pluripotent stem cells , 2014, BMC Research Notes.

[8]  Shinya Yamanaka,et al.  iPS cells: a game changer for future medicine , 2014, The EMBO journal.

[9]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[10]  E. Snyder,et al.  Current Protocols in Stem Cell Biology , 2007 .

[11]  Stephen Dalton,et al.  Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells , 2010, Hepatology.

[12]  L. Sullivan,et al.  Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines. , 2013, Blood.

[13]  Y. Liu,et al.  iPSC Reprogramming from Human Peripheral Blood Using Sendai Virus Mediated Gene Transfer , 2014 .

[14]  G. Daley,et al.  Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells , 2009, Nature Biotechnology.

[15]  Daniel Paull,et al.  Improved Methods for Reprogramming Human Dermal Fibroblasts Using Fluorescence Activated Cell Sorting , 2013, PloS one.

[16]  N. Katsanis,et al.  Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood , 2015, Stem Cell Reviews and Reports.

[17]  T. Cheng,et al.  A Facile Method to Establish Human Induced Pluripotent Stem Cells From Adult Blood Cells Under Feeder‐Free and Xeno‐Free Culture Conditions: A Clinically Compliant Approach , 2015, Stem cells translational medicine.

[18]  Michael J. Ziller,et al.  Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines , 2011, Cell.

[19]  Bahram Valamehr,et al.  A novel platform to enable the high-throughput derivation and characterization of feeder-free human iPSCs , 2012, Scientific Reports.

[20]  R. Lafyatis,et al.  Generation of Transgene‐Free Lung Disease‐Specific Human Induced Pluripotent Stem Cells Using a Single Excisable Lentiviral Stem Cell Cassette , 2010, Stem cells.

[21]  Y. Matsumoto,et al.  Genetically Matched Human iPS Cells Reveal that Propensity for Cartilage and Bone Differentiation Differs with Clones, not Cell Type of Origin , 2013, PloS one.

[22]  Jarrett Rosenberg,et al.  Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. , 2011, The Journal of clinical investigation.

[23]  Vicky Heath Differentiation: from α to β , 2010, Nature Reviews Endocrinology.

[24]  Ramesh Chandra,et al.  Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery , 2015, Front. Cell Dev. Biol..

[25]  T. Cantz,et al.  Small but significant: inter- and intrapatient variations in iPS cell-based disease modeling. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  Xin Ren,et al.  COMPARISON OF THE SORTING EFFICIENCY AND INFLUENCE ON CELL FUNCTION BETWEEN THE STERILE FLOW CYTOMETRY AND IMMUNOMAGNETIC BEAD PURIFICATION METHODS , 2013, Preparative biochemistry & biotechnology.

[27]  M. Hasegawa,et al.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[28]  P. Cahan,et al.  Origins and implications of pluripotent stem cell variability and heterogeneity , 2013, Nature Reviews Molecular Cell Biology.

[29]  A. Terzic,et al.  Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.